In addition, many studies have investigated the role of AFP-L3/AFP, alone or in combination with AFP and/or des-gamma carboxyprothrombin (DCP), as a screening marker for HCC [15,18-20]. This evidence concerns the gene AFP and hepatocellular carcinoma.